Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company MABLife S.A.S
DescriptionChimeric mAb targeting a non-GPI transmembrane isoform of the CD160 receptor
Molecular Target CD160
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today